Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

79.1K
Overview
79.1K
Tissue Transplantation01:24

Tissue Transplantation

677
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
677
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

394
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
394
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

131
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
131
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

119
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
119

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN·2026
Same author

A Pre-Kidney Transplant Blood-Based Next-Generation Sequencing Assay to Predict Early Acute Rejection.

Kidney360·2026
Same author

Combination Automated Microfluidics Measurement of Urine C-C Motif Ligand 2, CXC-Motif Chemokine 9, CXC-Motif Chemokine 10, and Vascular Endothelial Growth Factor A for Monitoring Patients with a Kidney Transplant.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Extreme phenotype sampling and next generation sequencing to identify genetic variants associated with tacrolimus in African American kidney transplant recipients.

The pharmacogenomics journal·2024
Same author

Poised for Innovation: Considerations for End Points for New Drug Development in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN·2024
Same author

Steroid-tacrolimus drug-drug interaction and the effect of CYP3A genotypes.

British journal of clinical pharmacology·2024

Related Experiment Video

Updated: Nov 10, 2025

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.2K

Chronic Allograft Injury.

Eric Langewisch1, Roslyn B Mannon1,2

  • 1Division of Nephrology, Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska.

Clinical Journal of the American Society of Nephrology : CJASN
|April 6, 2021
PubMed
Summary

Kidney transplant failure stems from chronic allograft injury, involving both immune and non-immune causes targeting kidney structures. Further research is needed to identify injury markers and mechanisms for better therapeutic strategies.

Keywords:
allograftschronic allograft failurekidney transplantation seriesrenal fibrosisrenal injurytransplantation

More Related Videos

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection
06:59

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection

Published on: February 2, 2022

4.1K
Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

13.9K

Related Experiment Videos

Last Updated: Nov 10, 2025

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.2K
A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection
06:59

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection

Published on: February 2, 2022

4.1K
Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

13.9K

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Pathology

Background:

  • Long-term kidney transplant survival has improved, shifting focus to causes of late graft failure.
  • Chronic allograft injury, encompassing immune and non-immune insults, damages kidney structures over time.
  • Persistent inflammation can lead to maladaptive repair, fibrosis, and eventual graft dysfunction.

Purpose of the Study:

  • To review recent findings on the etiologies and mechanisms of chronic allograft injury.
  • To highlight potential therapeutic targets for preventing late kidney transplant failure.
  • To identify unmet needs in understanding graft failure mechanisms.

Main Methods:

  • Review of recent cohort studies in humans.
  • Analysis of immune-mediated and non-immune-mediated injury pathways.
  • Synthesis of current knowledge on targets of injury and repair processes.

Main Results:

  • Chronic allograft injury involves diverse insults affecting tubular epithelium, endothelium, and glomeruli.
  • Fibrosis and matrix deposition are key outcomes of persistent inflammation.
  • Recent studies emphasize immune-mediated injuries, but a broader understanding is crucial.

Conclusions:

  • Understanding the mechanisms of chronic allograft injury is essential for improving long-term kidney transplant outcomes.
  • Identifying individuals at higher risk requires further research into injury markers and mechanisms.
  • Novel therapeutic strategies are needed to address the complex causes of late graft failure.